Initial Experience With the AngioVac Venous Drainage Cannula

Completed

Conditions studied: Heart Disease

In brief

This is a retrospective, record-based study of approximately 100 patients across up to 12 centers within the United States. All patients who have been treated with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit will be considered for study participation. Eligible subject must meet all of the inclusion criteria and none of the exclusion criteria to be considered enrolled in the study. The purpose of the study is to describe initial experience with the AngioVac Venous Drainage Cannula and the Extracorporeal Circuit.

Key facts

Study ID

NCT02775565

Run by

Angiodynamics, Inc.

People needed

51

Starts

2016-02-01

Expected to finish

2017-05-01

Last updated by the study team

2017-12-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Consecutive patients treated at each study site between February 1, 2013 and February 28, 2015 will be included.

You may not qualify if…

• Patients treated with the AngioVac venous drainage system outside of those dates.

Where it is running

• Providence St. Joseph — Burbank, California, United States
• UCLA — Los Angeles, California, United States
• Sanford Research — Fargo, North Dakota, United States
• MUSC — Charleston, South Carolina, United States
• Swedish Health Services — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.